Novavax, Inc.

NASDAQ:NVAX  
51.63
-0.18 (-0.35%)
4:57:01 PM EDT: $51.31 -0.32 (-0.62%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.02B
Current PEN/A
Forward PE 2.2
2yr Forward PE 5.2
See more stats
Estimates Current Quarter
Revenue$996.63 Million
Adjusted EPS$5.27
See more estimates
10-Day MA$45.58
50-Day MA$49.72
200-Day MA$116.21
See more pivots

Novavax, Inc. Stock, NASDAQ:NVAX

21 Firstfield Road, Gaithersburg, Maryland 20878
United States of America
Phone: +1.240.268.2000
Number of Employees: 1541

Description

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.